Sikkim Journal

Soft Tissue Sarcoma Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | OncoTherapy Science, Foghorn Therapeutics, C4 Therapeutics, Lyvgen Biopharma

Soft Tissue Sarcoma Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | OncoTherapy Science, Foghorn Therapeutics, C4 Therapeutics, Lyvgen Biopharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Soft Tissue Sarcoma pipeline constitutes 70+ key companies continuously working towards developing 75+ Soft Tissue Sarcoma treatment therapies, analysis of

Read Full Article

HER2 Negative Breast Cancer Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Context Therapeutics, Boehringer Ingelheim, CytomX Therapeutics, Beta Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, HER2 Negative Breast Cancer pipeline constitutes 70+ key companies continuously working towards developing 85+ HER2 Negative Breast Cancer treatment therapies,

Read Full Article

Hong Kong International Automotive & Supply Chain Expo Kicks Off: “Phoenix Go Glocal” Empowers Auto Enterprises on a “New Journey” of Global Expansion

HONG KONG – The 2025 International Automotive Supply Chain Expo (Hong Kong), co-hosted by the China Association of Automobile Manufacturers, Hong Kong Chinese Enterprises Association, The Chinese Manufacturers’ Association of

Read Full Article

From Immigrant Hustle to Identity-Driven Success: How Coach Yasin Is Helping Entrepreneurs and Immigrants Reclaim Purpose and Power

Cardiff, UK – June 13, 2025 – In a coaching world flooded with motivational fluff and recycled strategies, one voice is cutting through the noise with lived experience, cultural insight,

Read Full Article

Cutaneous T-cell Lymphoma Market on Track for Major Expansion by 2034, According to DelveInsight | Innate Pharma, Galderma R&D, Kyowa Kirin, Citius Pharma, Soligenix, 4SC AG, oligenix, Ligand Pharma

The Key Cutaneous T-cell Lymphoma Companies in the market include – Citius Pharmaceuticals, Soligenix, 4SC AG, Innate Pharma, Galderma R&D,

Read Full Article

Kiwibit Expands Into Outdoor Living With Beako™ Smart Bird Feeder – A 4K, AI-Powered Solar Feeder That Redefines Backyard Birdwatching

Kiwibit, a newcomer in the smart tech space, is excited to introduce Beako™, a new addition to its product portfolio

Read Full Article

SalesPlastics.com Launches Global Platform for Polymer Resin Buyers and Industrial Manufacturers

Jiaxing, China – June 13, 2025 – SalesPlastics.com, a China-based supplier of plastic and polymer resins, has officially launched its international

Read Full Article

Graft vs Host Disease Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Cellestia Biotech, Pfizer, Chia Tai Tianqing Pharma, Regimmune Corp

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Graft vs Host Disease pipeline constitutes 45+ key companies continuously

Read Full Article

Justicia Empresarial Launches Comprehensive Support Services for US Investors Amid New Tariff Policies

In response to the recent implementation of the “Liberation Day” tariffs by US President, Justicia Empresarial is proud to announce

Read Full Article

Hypertriglyceridemia Pipeline 2025: Key Developments, Emerging Therapies, and Clinical Trials Detailed Analysis by DelveInsight | Merck, Julphar, Eli Lilly and Company, Bristol-Myers Squibb Company

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hypertriglyceridemia pipeline constitutes 18+ key companies continuously working towards developing

Read Full Article